lipopolysaccharide promotes the metastatic potential of lung carcinoma cells by upregulating the...

5
@ IJTSRD | Available Online @ www ISSN No: 245 Inte R Lipopolysaccharide p Carcinoma Cells by U Asif Amin National Post-Doctoral Fello National Institute of Immunol New Delhi, India Asrar H. Wafai Senior Research Fellow Department of Biotechnolog University of Kashmir, Srinagar, J& ABSTRACT Lipopolysaccharide (LPS) stimula mediated signalling has been shown to a metastasis in a variety of cancers. mammary cancer model, LPS has be trigger lung metastasis. However there studies which report the pro-tumor prop in lung cancer. In this study we investiga of LPS on Fibronectin induced metastati in human lung cancer cells. Lower con LPS exhibited a pro-proliferative eff cells. Using such concentrations of LPS A549 cells, expression of Fibrone increased in comparison to control. 0. treatment led to the two fold increas expression of Fibronectin. Moreover, LP augmented the migratory ability of A assessed by wound healing assay. Thi migration of A549 cells was in agreem expression pattern of Fibronectin indu stimulation. Taken together this stud preliminary account of the role of LPS in expression of Fibronectin and metastati in lung carcinoma. Keywords: Lipopolysaccharide; Fibro Carcinoma w.ijtsrd.com | Volume – 2 | Issue – 1 | Nov-Dec 56 - 6470 | www.ijtsrd.com | Volum ernational Journal of Trend in Sc Research and Development (IJT International Open Access Journ promotes the metastatic Potent Upregulating the Expression of ow logy Taseem A. Mo Senior Researc Department of Bio University of Kashmir, S gy &K, India Raies A. Q Professor & Department of Bio University of Kashmir, S ated TLR-4 accentuate the In a murine een found to are very few perties of LPS ated the effect tic progression ncentrations of fect on A549 S to stimulate ectin mRNA .5 µg of LPS ase in mRNA PS stimulation A549 cells as is increase in ment with the uced by LPS dy presents a n inducing the ic progression onectin; Lung I. INTRODUCTION Lipopolysaccharide (LPS) al constitutes the major molec outer membrane of Gram-neg immune system recognizes bacterial invasion. Toll like r innate immune mechanism mediating the host inflam recognizing signature mo surfaces referred to as pathog patterns (PAMPs) such as L formed between TLR4 and factor (MD2) represents a ma for lipopolysaccharide. LPS b receptor complex and init signaling cascade leading to t downstream Mitogen-Activat MyD88-dependant or MyD8 Such signaling cascades have roles in cell proliferation, apo 5). The role of LPS is tumor pro remains controversial with b properties being reported. properties of LPS have b treatment of colorectal can c 2017 Page: 1022 me - 2 | Issue 1 cientific TSRD) nal tial of Lung Fibronectin okhdomi ch Fellow otechnology Srinagar, J&K, India Qadri & Head otechnology Srinagar, J&K, India lso known as endotoxin cular component of the gative bacteria. The host LPS as a marker of receptors (TLRs) as an play a pivotal role in mmatory responses by olecules on microbial gen associat ed molecular LPS (1,2). The complex myeloid differentiation ajor cell surface receptor binds to the TLR4/MD2 tiates the intracellular the activation of various ted Protein Kinases in a 88-independent manner. e been shown to play key optosis, and adhesion (3- ogression and metastasis both anti and pro-tumor The anti-tumorigenic been reported for the ncer and glioblastoma

Upload: ijtsrd

Post on 12-Aug-2019

3 views

Category:

Education


0 download

DESCRIPTION

Lipopolysaccharide LPS stimulated TLR 4 mediated signalling has been shown to accentuate the metastasis in a variety of cancers. In a murine mammary cancer model, LPS has been found to trigger lung metastasis. However there are very few studies which report the pro tumor properties of LPS in lung cancer. In this study we investigated the effect of LPS on Fibronectin induced metastatic progression in human lung cancer cells. Lower concentrations of LPS exhibited a pro proliferative effect on A549 cells. Using such concentrations of LPS to stimulate A549 cells, expression of Fibronectin mRNA increased in comparison to control. 0.5 µg of LPS treatment led to the two fold increase in mRNA expression of Fibronectin. Moreover, LPS stimulation augmented the migratory ability of A549 cells as assessed by wound healing assay. This increase in migration of A549 cells was in agreement with the expression pattern of Fibronectin induced by LPS stimulation. Taken together this study presents a preliminary account of the role of LPS in inducing the expression of Fibronectin and metastatic progression in lung carcinoma. Asif Amin | Taseem A. Mokhdomi | Asrar H. Wafai | Raies A. Qadri "Lipopolysaccharide promotes the metastatic Potential of Lung Carcinoma Cells by Upregulating the Expression of Fibronectin" Published in International Journal of Trend in Scientific Research and Development (ijtsrd), ISSN: 2456-6470, Volume-2 | Issue-1 , December 2017, URL: https://www.ijtsrd.com/papers/ijtsrd7164.pdf Paper URL: http://www.ijtsrd.com/biological-science/cell-biology/7164/lipopolysaccharide-promotes-the-metastatic-potential-of-lung-carcinoma-cells-by-upregulating-the-expression-of-fibronectin/asif-amin

TRANSCRIPT

Page 1: Lipopolysaccharide promotes the metastatic Potential of Lung Carcinoma Cells by Upregulating the Expression of Fibronectin

@ IJTSRD | Available Online @ www.ijtsrd.com

ISSN No: 2456

InternationalResearch

Lipopolysaccharide promotes the metastatic Potential of Lung Carcinoma Cells by Upregulating the Expression of Fibronectin

Asif Amin National Post-Doctoral Fellow

National Institute of ImmunologyNew Delhi, India

Asrar H. Wafai

Senior Research Fellow Department of Biotechnology

University of Kashmir, Srinagar, J&K,

ABSTRACT

Lipopolysaccharide (LPS) stimulated TLRmediated signalling has been shown to accentuate the metastasis in a variety of cancers. In a murine mammary cancer model, LPS has been found to trigger lung metastasis. However there are very few studies which report the pro-tumor properties of LPS in lung cancer. In this study we investigated the effect of LPS on Fibronectin induced metastatic progression in human lung cancer cells. Lower concentraLPS exhibited a pro-proliferative effect on A549 cells. Using such concentrations of LPS to stimulate A549 cells, expression of Fibronectin mRNA increased in comparison to control. 0.5 µg of LPS treatment led to the two fold increase in mRNA expression of Fibronectin. Moreover, LPS stimulation augmented the migratory ability of A549 cells as assessed by wound healing assay. This increase in migration of A549 cells was in agreement with the expression pattern of Fibronectin induced by LPS stimulation. Taken together this study presents a preliminary account of the role of LPS in inducing the expression of Fibronectin and metastatic progression in lung carcinoma.

Keywords: Lipopolysaccharide; Fibronectin; Lung Carcinoma

@ IJTSRD | Available Online @ www.ijtsrd.com | Volume – 2 | Issue – 1 | Nov-Dec 2017

ISSN No: 2456 - 6470 | www.ijtsrd.com | Volume

International Journal of Trend in Scientific Research and Development (IJTSRD)

International Open Access Journal

Lipopolysaccharide promotes the metastatic Potential of Lung Carcinoma Cells by Upregulating the Expression of Fibronectin

Doctoral Fellow National Institute of Immunology

Taseem A. MokhdomiSenior Research

Department of BiotechnologyUniversity of Kashmir, Srinagar, J&K,

Department of Biotechnology

Srinagar, J&K, India

Raies A. QadriProfessor & Head

Department of BiotechnologyUniversity of Kashmir, Srinagar, J&K, India

Lipopolysaccharide (LPS) stimulated TLR-4 mediated signalling has been shown to accentuate the metastasis in a variety of cancers. In a murine mammary cancer model, LPS has been found to

igger lung metastasis. However there are very few tumor properties of LPS

in lung cancer. In this study we investigated the effect of LPS on Fibronectin induced metastatic progression in human lung cancer cells. Lower concentrations of

proliferative effect on A549 cells. Using such concentrations of LPS to stimulate A549 cells, expression of Fibronectin mRNA increased in comparison to control. 0.5 µg of LPS treatment led to the two fold increase in mRNA

ssion of Fibronectin. Moreover, LPS stimulation augmented the migratory ability of A549 cells as assessed by wound healing assay. This increase in migration of A549 cells was in agreement with the expression pattern of Fibronectin induced by LPS

n. Taken together this study presents a preliminary account of the role of LPS in inducing the expression of Fibronectin and metastatic progression

Lipopolysaccharide; Fibronectin; Lung

I. INTRODUCTION

Lipopolysaccharide (LPS) also known as endotoxinconstitutes the major molecular component of the outer membrane of Gram-negative bacteria. immune system recognizes LPS bacterial invasion. Toll like receptors (innate immune mechanism play a mediating the host inflammatory responsesrecognizing signature moleculessurfaces referred to as pathogen associatpatterns (PAMPs) such as LPSformed between TLR4 and myeloid differentiation factor (MD2) represents a major cell surface receptor for lipopolysaccharide. LPS bindreceptor complex and initiates the intracellular signaling cascade leading to the activation of various downstream Mitogen-Activated Protein Kinases MyD88-dependant or MyD88Such signaling cascades have been shown to play key roles in cell proliferation, apoptosis, and adhesion 5).

The role of LPS is tumor progression and metastasis remains controversial with both anti and proproperties being reported. properties of LPS have been reported for the treatment of colorectal cancer and glioblastoma

Dec 2017 Page: 1022

| www.ijtsrd.com | Volume - 2 | Issue – 1

Scientific (IJTSRD)

International Open Access Journal

Lipopolysaccharide promotes the metastatic Potential of Lung Carcinoma Cells by Upregulating the Expression of Fibronectin

Taseem A. Mokhdomi Research Fellow

Department of Biotechnology Srinagar, J&K, India

Raies A. Qadri Professor & Head

artment of Biotechnology Srinagar, J&K, India

Lipopolysaccharide (LPS) also known as endotoxin constitutes the major molecular component of the

negative bacteria. The host immune system recognizes LPS as a marker of

Toll like receptors (TLRs) as an innate immune mechanism play a pivotal role in

the host inflammatory responses by signature molecules on microbial

as pathogen associated molecular LPS (1,2). The complex

formed between TLR4 and myeloid differentiation a major cell surface receptor

LPS binds to the TLR4/MD2 initiates the intracellular

leading to the activation of various Activated Protein Kinases in a

D88-independent manner. have been shown to play key

ation, apoptosis, and adhesion (3-

The role of LPS is tumor progression and metastasis with both anti and pro-tumor

. The anti-tumorigenic been reported for the

treatment of colorectal cancer and glioblastoma

Page 2: Lipopolysaccharide promotes the metastatic Potential of Lung Carcinoma Cells by Upregulating the Expression of Fibronectin

International Journal of Trend in Scientific Research and Development (IJTSRD) ISSN: 2456-6470

@ IJTSRD | Available Online @ www.ijtsrd.com | Volume – 2 | Issue – 1 | Nov-Dec 2017 Page: 1023

multiforme. An increasing body of evidence also points at the role of LPS in tumor progression. Stimulation of TLR4 by LPS has been found to trigger increased lung metastasis in a murine mammary cancer model of metastatic disease. This effect was ascribed to an increased proliferation and inhibition of apoptosis of tumor cells as well as an tumor cell invasion and migration along with increased angiogenesis (6,7). Besides this study, TLR4 has been implicated in tumor cell invasion, survival, and metastasis in many cancer types (8). A recent study demonstrated that LPS can increase the migration ability of human cell esophageal cancer HKESC-2 cells via signaling through TLR4 (9). Similarly in breast cancer TLR4 activation by LPs has been shown to promote the αvβ3-mediated adhesion and invasiveness (10).

II. Materials and Methods

A. Chemicals and reagents

DMEM and FBS were procured from Gibco, USA. Penstrip was obtained from Invitrogen, USA. LPS (Escherichia coli 0111:B4), DMSO and MTT were purchased from Sigma Chemical Co. (St. Louis, MO, USA). LPS was prepared as a stock solution of 1 mg/ml and was diluted to various concentrations with serum free medium when used.

B. Cell culture

Human lung carcinoma cell line, A549 was provided by Dr. Ayub Qadri, National Institute of Immunology. A549 Cells were cultured in DMEM, supplemented with 10% fetal bovine serum, and antibiotics (1% penstrip) at 37 °C in 5% CO2 humidified incubator. The medium was changed regularly and the cells were sub-cultured when confluent.

C. MTT Cell Proliferation Assay

Cells were seeded into the wells of a 96 well plate and allowed to grow overnight. LPS was added to cells at various concentrations (0.1, 0.5, 1, 1.5, 2 and 2.5 μg) for 24 h. Following treatment, 100 µl of MTT solution was added to each well followed by 2 h incubation at 37°C in dark. Then the MTT solution was removed and 100 µl of DMSO was added to cells. The quantification was done by measuring the absorbance at 590 nm (background 650 nm) using micro plate reader (Biotek, USA) and the percentage proliferation was calculated.

D. Reverse transcriptase polymerase chain reaction

RNA was isolated using TRIzol reagent according to manufacturer’s instructions. Briefly 1 ml of TRIzol was added to the cells grown in 30 mm culture dish followed by homogenization using a pipette. Thereafter 1ml of sterile water was added and the mixture incubated at room temperature for 5-15 min. The mixture was centrifuged at 12,000 g for 15 min and supernatant collected, to which 70% isopropanol was added. The supernatant was further centrifuged at 12,000 g for 10 min to obtain the RNA pellet which was washed two times with 75% ethanol. The integrity of RNA was checked on 1% agarose gel. In succession to RNA isolation and subsequent quantification, RNA was reverse transcribed to cDNA using reverse transcriptase and oligo-dT primers in a final volume of 20 μl.

The primers used for evaluating the expression status of Fibronectin are as:

Forward primer 5…AGTCAGCCTCTGGTTCAGAC...3

Reverse primer 5…CTTCAGGTCAGTTGGTGCAG...3

PCR products were analyzed on 1–2% agarose gels and the ratio of TLR4 to β-actin served as the level of mRNA expression.

E. Real Time PCR

Real-time PCR was performed to detect the gene expression of Fibronectin in A549 cells under LPS stimulation. The 10 µl reaction mixture contained 5.5 µl nuclease-free water, 1.0 ml cDNA (1 mg/ml), 0.5 µl (10 mM) each primer and 2.5 µl Light Cycler 480 SYBR Green Master (Roche, Germany). The amplification was carried at 94 °C for 2 min incubation and 40 cycles of 94 °C for 15 s, 56 °C for 15 s, 72 °C for 20 s, followed by final extension of 72 °C for 2 min in LightCycler 480 II (Roche, Germany). Relative quantification was done using 2-

ΔΔcp method (11).

F. Cell migration Assay

Equal number of A549 cells was seeded in each well of 24-well plate and allowed to grow to sub-confluency. Then the scratch was created using a 100 μl pipette tip followed by washings with PBS to

Page 3: Lipopolysaccharide promotes the metastatic Potential of Lung Carcinoma Cells by Upregulating the Expression of Fibronectin

International Journal of Trend in Scientific

@ IJTSRD | Available Online @ www.ijtsrd.com

remove the floating cells. This was followed by treatment with sub-toxic concentrations of LPS for 24 h. Photographs were taken before (0 h) and after treatment at 24 h. Wound healing was calculated as the percentage of the initial wound before treatment to the total wound closure at 24 h after treatment. The assay was performed three independent times.

III. RESULTS

A. Determination of Sub-lethal doses of LPS

Exposure to bacterial LPS has been shown to induce apoptotic cell death. In order to determine the lethal doses of LPS, A549 cells were treated with different concentrations of LPS. It was observed that LPS did not result in appreciable inhibition of cproliferation up to 1μg of LPS. However exceeding 1μg had a significant impact on the proliferation of A549 cells. Therefore we only used sub-lethal concentrations of LPS for further (Figure 1).

Figure 1. Evaluation of sub-lethal dosA549 cells by MTT assay. A549 cells were treated with the indicated concentrations of LPS for 24 h. After 24 h, cytotoxicity was determined by MTT assay. Data represented as mean ± SD of results from three independent experiments.

B. Treatment with LPS increases the expression of Fibronectin in A549 cells

Fibronectin has been shown to promote metastatic behavior of many tumors including those of lung. Therefore to assess the effect of LPS on the expression of Fibronectin, A549 cells to various sub-lethal concentrations (0.1, 0.5 and 1

International Journal of Trend in Scientific Research and Development (IJTSRD) ISSN: 2456

@ IJTSRD | Available Online @ www.ijtsrd.com | Volume – 2 | Issue – 1 | Nov-Dec 2017

remove the floating cells. This was followed by toxic concentrations of LPS for 24

h. Photographs were taken before (0 h) and after as calculated as

the percentage of the initial wound before treatment to the total wound closure at 24 h after treatment. The assay was performed three independent times.

doses of LPS

Exposure to bacterial LPS has been shown to induce order to determine the Sub-

were treated with different concentrations of LPS. It was observed that LPS did not result in appreciable inhibition of cell

g of LPS. However the doses g had a significant impact on the

proliferation of A549 cells. Therefore we only used lethal concentrations of LPS for further assays

doses of LPS on A549 cells by MTT assay. A549 cells were treated with the indicated concentrations of LPS for 24 h. After 24 h, cytotoxicity was determined by MTT assay. Data represented as mean ± SD of results from

with LPS increases the expression of

Fibronectin has been shown to promote metastatic behavior of many tumors including those of lung.

to assess the effect of LPS on the cells were exposed

(0.1, 0.5 and 1

μg) of LPS for 24 h. Following treatment, RNA was isolated from A549 cells using trizol reagent2).

Figure 2. RNA isolation from treated cells

The extracted RNA was reverse transcribed to cDNA using oligo dT primers. To evaluate the effect of LPS treatment on the expression of Fibronectin at mRNA level, cDNA obtained was amplified using specific primers. It was observed that the treatment with LPled to the increase in the expression of particularly at 0.6 µg concentration (Figure 3 AHowever at 0.1 µg there was decrease in the gene expression of Fibronectin as compared to untreated control. For further quantitative analysis, realPCR was carried out and the results obtained were in consonance with those obtained by semianalysis (Figure 3B). Realrevealed that the Fibronectin gene expression gets upregulated 2 fold using 0.6 µg LPS in comparisionto untreated control.

Research and Development (IJTSRD) ISSN: 2456-6470

Dec 2017 Page: 1024

h. Following treatment, RNA was isolated from A549 cells using trizol reagent (Figure

. RNA isolation from control and LPS

The extracted RNA was reverse transcribed to cDNA using oligo dT primers. To evaluate the effect of LPS treatment on the expression of Fibronectin at mRNA level, cDNA obtained was amplified using specific primers. It was observed that the treatment with LPS led to the increase in the expression of Fibronectin

g concentration (Figure 3 A). However at 0.1 µg there was decrease in the gene expression of Fibronectin as compared to untreated

For further quantitative analysis, real-time PCR was carried out and the results obtained were in consonance with those obtained by semi-quantitative

Real-Time PCR analysis revealed that the Fibronectin gene expression gets upregulated 2 fold using 0.6 µg LPS in comparision

Page 4: Lipopolysaccharide promotes the metastatic Potential of Lung Carcinoma Cells by Upregulating the Expression of Fibronectin

International Journal of Trend in Scientific

@ IJTSRD | Available Online @ www.ijtsrd.com

Figure 3. Gene expression analysis of Fibronectin LPS stimulated A549 cells by (A) Semi quantitareverse transcription PCR (B) Real Time PCRrepresented as mean ± SD of results from three independent experiments.

Figure 4. Effect of LPS on the migration of A549 cells. A549 cells were grown to suband treated with indicated concentrations of LPS or left untreated 24h. (B) The data calculated from three independent experiments and represented as mean ± SD.

IV. DISCUSSION

Fibronectin is an extracellular matrix glycoprotein that has been shown to promote metastatic process in a wide variety of cancer types. It has been implicated in

International Journal of Trend in Scientific Research and Development (IJTSRD) ISSN: 2456

@ IJTSRD | Available Online @ www.ijtsrd.com | Volume – 2 | Issue – 1 | Nov-Dec 2017

Fibronectin in by (A) Semi quantitative

reverse transcription PCR (B) Real Time PCR. Data represented as mean ± SD of results from three

C. Treatment with LPS accentuates the migration of A549 cells

Migration and invasion represent the processes crucial to metastasis. Fibronectin has been shown to enhance the migration and invasiveness of lung carcinoma cells. To evaluate the effect of LPS migration of A549 cells, a wound healing assay was carried out. A549 cells were grown to confluency, wounded and then treated with indicated concentration of LPS. It was observed stimulation led to the healing of wconcentration being 0.5 μg. In terms of percentage wound healing, while treatment with 1 μg and 0.5led to the healing of wound to about 86% and 95% respectively while as 0.1 μg was not much effective when compared with the control

Effect of LPS on the migration of A549 cells. A549 cells were grown to suband treated with indicated concentrations of LPS or left untreated (control). (A) Wound healing observed 24h. (B) The data calculated from three independent experiments and represented as mean ± SD.

Fibronectin is an extracellular matrix glycoprotein that has been shown to promote metastatic process in a wide

It has been implicated in

promoting the tumor cell migration and invasion (12). Of particular importance is its role inmesenchymal transition which is a cellular program indispensible to cancer metastasisassociated molecular patterns such as LPS have

Research and Development (IJTSRD) ISSN: 2456-6470

Dec 2017 Page: 1025

Treatment with LPS accentuates the migration

Migration and invasion represent the processes Fibronectin has been shown to

enhance the migration and invasiveness of lung carcinoma cells. To evaluate the effect of LPS on the migration of A549 cells, a wound healing assay was

A549 cells were grown to confluency, wounded and then treated with indicated

. It was observed that LPS stimulation led to the healing of wound with best

. In terms of percentage healing, while treatment with 1 μg and 0.5 μg

led to the healing of wound to about 86% and 95% respectively while as 0.1 μg was not much effective when compared with the control (Figure 4).

Effect of LPS on the migration of A549 cells. A549 cells were grown to sub-confluency, wounded (control). (A) Wound healing observed after

24h. (B) The data calculated from three independent experiments and represented as mean ± SD.

promoting the tumor cell migration and invasion (12). Of particular importance is its role in epithelial-mesenchymal transition which is a cellular program indispensible to cancer metastasis (13). Pathogen associated molecular patterns such as LPS have

Page 5: Lipopolysaccharide promotes the metastatic Potential of Lung Carcinoma Cells by Upregulating the Expression of Fibronectin

International Journal of Trend in Scientific Research and Development (IJTSRD) ISSN: 2456-6470

@ IJTSRD | Available Online @ www.ijtsrd.com | Volume – 2 | Issue – 1 | Nov-Dec 2017 Page: 1026

profound consequences on tumor growth as they have been found to promote cancer progression and anti-apoptotic activity (6-8). In a recent study NADPH oxidase 1-dependent ROS was demonstrated to be crucial for TLR4 signaling to promote tumor metastasis of non-small cell lung cancer (14). In this way, we therefore designed this study to determine the action of LPS on Fibronectin induced metastatic progression in lung carcinoma cells. A549 cells were stimulated with sub-lethal doses of LPS. At such concentrations there was an increase in the proliferation of these cells. Furthermore treatment with such concentrations led to increase in the expression of Fibronectin at mRNA level as was assessed by semi-quantitative reverse transcription PCR as well as quantitative real time PCR. To further assess the effect of LPS on the migration, A549 cells were treated with sub-lethal concentrations of LPS. It was observed that the treatment with LPS increased the migratory ability of A549 cells as was depicted by significant closure of the wound. The finding was in coherence with the upregulation of Fibronectin by LPS treatment. Thus it can be argued that LPS accentuates the metastatic process in lung cancer cells by upregulating the expression of Fibronectin. The present study presents a preliminary account of effect of LPS on Fibronectin induced metastatic progression in lung carcinoma and thus warrants an exhaustive study to discern the mechanistic action of LPS.

References

1) [1] Janeway CA Jr, Medzhitov R. (2002) Innate immune recognition. Annual Reviews of Immunolgy. 20: 197–216.

2) [2] Akira S, Uematsu S, Takeuchi O. (2006) Pathogen recognition and innate immunity. Cell 124: 783–801.

3) [3] Kim HM, Park BS, Kim JI, Kim SE, Lee J, Oh SC, et al (2007) Crystal structure of the TLR4-MD-2 complex with bound endotoxin antagonist Eritoran. Cell 130: 906–17.

4) [4] Park BS, Song DH, Kim HM, Choi BS, Lee H, Lee JO. (2009) The structural basis of lipopolysaccharide recognition by the TLR4-MD-2 complex. Nature 458: 1191–5.

5) [5] Lu YC, Yeh WC, Ohashi PS. (2008). LPS/TLR4 signal transduction pathway. Cytokine 42: 145–51.

6) [6] Pidgeon GP, Harmey JH, Kay E, Da Costa M, Redmond HP, Bouchier-Hayes DJ. (1999) The role

of endotoxin/lipopolysaccharide in surgically induced tumour growth in a murine model of metastatic disease. British Journal of Cancer. 81: 1311–7.

7) [7] Harmey JH, Bucana CD, Lu W, Byrne AM, McDonnell S, Lynch C, et al. (2002) Lipopolysaccharide-induced metastatic growth is associated with increased angiogenesis, vascular permeability and tumor cell invasion. International Journal of Cancer.101: 415–22.

8) [8] Yang H, Wang B, Wang T, Xu L, He C, Wen H, et al. (2014) Toll-like receptor 4 prompts human breast cancer cells invasiveness via lipopolysaccharide stimulation and is overexpressed in patients with lymph node metastasis. PLoS ONE .9: e109980

9) [9] Rousseau MC, Hsu RY, Spicer JD, Mcdonald B, Chan CH, Perera RM, et al. (2013) Lipopolysaccharide-induced toll-like receptor 4 signaling enhances the migratory ability of human esophageal cancer cells in a selectindependent manner. Surgery.154: 69-77.

10) [10] Liao SJ, Zhou YH, Yuan Y, Li D, Wu FH, et al. (2012) Triggering of Toll-like receptor 4 on metastatic breast cancer cells promotes avb3-mediated adhesion and invasive migration. Breast Cancer Research and Treatment. 133: 853–63.

11) [11] Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using real- time quantitative PCR and the 2-ΔΔcp Method. Methods. 25: 402–408

12) [12] Ou, J., Peng, Y., Deng, J., Miao, H., Zhou, J., Zha, L., Liang, H. (2014). Endothelial cell-derived fibronectin extra domain A promotes colorectal cancer metastasis via inducing epithelial–mesenchymal transition. Carcinogenesis. 35: 1661–1670

13) [13] Amin, A., Chikan, N. A., Mokhdomi, T. A., Bukhari, S., Koul, A. M., Shah, B. A., & Qadri, R. A. (2016). Irigenin, a novel lead from Western Himalayan chemiome inhibits Fibronectin-Extra Domain A induced metastasis in Lung cancer cells. Scientific Reports. 6.

14) [14] Liu X, Pei C, Yan S, Liu G, Liu G, Chen W et al. (2015) NADPH oxidase 1-dependent ROS is crucial for TLR4 signaling to promote tumor metastasis of non-small cell lung cancer. Tumor Biology. 6: 1493–1502.